P009: Improved Overall Survival with First-Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1

• Martin Hutchings,
• Stephen M. Ansell,
• Joseph M. Connors,
• Won Seog Kim,
• Andrea Gallamini,
• Radhakrishnan Ramchandren,
• Jonathan W. Friedberg,
• Ranjana Advani,
• Andrew M. Evens,
• Piotr Smolewski,
• Kerry J. Savage,
• Nancy L. Bartlett,
• Hyeon-Seok Eom,
• Jeremy S. Abramson,
• Cassie Dong,
• Frank Campana,
• Keenan Fenton,
• Markus Puhlmann,
• David J. Straus,
• John Radford

Affiliations

Martin Hutchings

1 Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Stephen M. Ansell

2 Division of Hematology, Mayo Clinic, Rochester, MN, USA

Joseph M. Connors

3 BC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada

Won Seog Kim

4 Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Andrea Gallamini

5 Research and Innovation, Antoine-Lacassagne Cancer Centre, Nice, France

Radhakrishnan Ramchandren

6 The University of Tennessee Graduate School of Medicine, Knoxville, TN, USA

Jonathan W. Friedberg

7 James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA

Ranjana Advani

8 Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA

Andrew M. Evens

9 Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, USA

Piotr Smolewski

10 Department of Experimental Hematology, Medical University of Lodz, Lodz, Poland

Kerry J. Savage

3 BC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada

Nancy L. Bartlett

11 Washington University School of Medicine, Siteman Cancer Center, St Louis, MO, USA

Hyeon-Seok Eom

12 Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea

Jeremy S. Abramson

13 Massachusetts General Hospital, Boston, MA, USA

Cassie Dong

14 Takeda Development Center Americas, Inc. (TDCA), Lexington MA, USA

Frank Campana

14 Takeda Development Center Americas, Inc. (TDCA), Lexington MA, USA

Keenan Fenton

15 Seagen Inc., Bothell, WA, USA

Markus Puhlmann

15 Seagen Inc., Bothell, WA, USA

David J. Straus

16 Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

John Radford

17 The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom